Effect of YM-53601, a novel squalene synthase inhibitor, on the clearance rate of plasma LDL and VLDL in hamsters (Q41827579)

12 October 2017

Effect of YM-53601, a novel squalene synthase inhibitor, on the clearance rate of plasma LDL and VLDL in hamsters (English)

1 reference

12 October 2017

Tohru Ugawa

1

1 reference

12 October 2017

Hirotoshi Kakuta

series ordinal

2

1 reference

12 October 2017

Hiroshi Moritani

series ordinal

3

1 reference

12 October 2017

Osamu Inagaki

series ordinal

4

1 reference

12 October 2017

language of work or name

English

0 references

publication date

1 October 2002

1 reference

British Journal of Pharmacology

12 October 2017

1 reference

12 October 2017

137

1 reference

12 October 2017

4

1 reference

12 October 2017

561-569

1 reference

Protein measurement with the Folin phenol reagent

12 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1573526

Squalene synthase inhibitors reduce plasma triglyceride through a low-density lipoprotein receptor-independent mechanism

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1573526

Evidence that triglycerides are an independent coronary heart disease risk factor

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1573526

Receptor-mediated mechanisms of lipoprotein remnant catabolism

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1573526

RPR 107393, a potent squalene synthase inhibitor and orally effective cholesterol-lowering agent: comparison with inhibitors of HMG-CoA reductase

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1573526

The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1573526

The novel compound NO-1886 increases lipoprotein lipase activity with resulting elevation of high density lipoprotein cholesterol, and long-term administration inhibits atherogenesis in the coronary arteries of rats with experimental atherosclerosis

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1573526

Effect of squalene synthase inhibition on the expression of hepatic cholesterol biosynthetic enzymes, LDL receptor, and cholesterol 7 alpha hydroxylase

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1573526

The lipid-lowering profile in rodents AZ-1355, A New Dibenzoxazepine Derivative

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1573526

Rates of receptor-dependent and -independent low density lipoprotein uptake in the hamster

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1573526

Lipoprotein-receptor interactions

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1573526

Role of lysine residues of plasma lipoproteins in high affinity binding to cell surface receptors on human fibroblasts

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1573526

Ultracentrifugal studies of lipoproteins of human serum.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1573526

YM-53601, a novel squalene synthase inhibitor, reduces plasma cholesterol and triglyceride levels in several animal species

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1573526

Comparison of clofibrate and caloric restriction on kinetics of very low density lipoprotein triglycerides

18 August 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FSJ.BJP.0704906

Contribution of the receptor pathway to low density lipoprotein catabolism in humans. New methods for quantitation

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FSJ.BJP.0704906

Lipid-lowering and antiatherosclerotic effect of NK-104, a potent 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, in Watanabe heritable hyperlipidemic rabbits

21 January 2018

1 reference

12 December 2020

Determination of free amino groups in proteins by trinitrobenzenesulfonic acid

1 reference

12 December 2020

Influence of Gemfibrozil and Clofibrate on Metabolism of Cholesterol and Plasma Triglycerides in Man

1 reference

12 December 2020

A novel mechanism by which probucol lowers low density lipoprotein levels demonstrated in the LDL receptor-deficient rabbit

1 reference

12 December 2020

Intravenous lipid emulsions: removal mechanisms as compared to chylomicrons

1 reference

12 December 2020

Inhibitors of Cholesterol Biosynthesis Increase Hepatic Low-Density Lipoprotein Receptor Protein Degradation

1 reference

12 December 2020

STUDIES ON THE ELIMINATION OF EXOGENOUS LIPIDS FROM THE BLOOD STREAM. THE KINETICS OF THE ELIMINATION OF A FAT EMULSION AND OF CHYLOMICRONES IN THE DOG AFTER SINGLE INJECTION

1 reference

12 December 2020

Identifiers

DOI

10.1038/SJ.BJP.0704906

1 reference

12 October 2017

1 reference

12 October 2017

PubMed publication ID

12359639

1 reference